Immunotherapy is the most promising treatment for uveal melanoma patients with metastasis. Tumor microenvironment plays an essential role in tumor progression and greatly affects the efficacy of immunotherapy. This research constructed an immune-related subtyping system and discovered immune prognostic genes to further understand the immune mechanism in uveal melanoma. Immune-related genes were determined from literature. Gene expression profiles of uveal melanoma were clustered using consensus clustering based on immune-related genes. Subtypes were further divided by applying immune landscape, and weighted correlation network analysis was performed to construct immune gene modules. Univariate Cox regression analysis was conducted to generate a prognostic model. Enriched immune cells were determined after gene set enrichment analysis. Three major immune subtypes (IS1, IS2, and IS3) were identified, and IS2 could be further divided into IS2A and IS2B. The subtypes were closely associated with uveal melanoma prognosis. IS3 group had the most favorable prognosis and was sensitive to PD-1 inhibitor. Immune genes in IS1 group showed an overall higher expression than IS3 group. Six immune gene modules were identified, and the enrichment score of immune genes varied within immune subtypes. Four immune prognostic genes (IL32, IRF1, SNX20, and VAV1) were found to be closely related to survival. This novel immune subtyping system and immune landscape provide a new understanding of immunotherapy in uveal melanoma. The four prognostic genes can predict prognosis of uveal melanoma patients and contribute to new development of targeted drugs.
KrantzBADaveNKomatsubaraKMMarrBPCarvajalRD.Uveal melanoma: epidemiology, etiology, and treatment of primary disease. Clin Ophthalmol2017;
11:279–89
2.
AronowMETophamAKSinghAD.Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013). Ocul Oncol Pathol2018;
4:145–51
3.
SisleyKRennieIGParsonsMAJacquesRHammondDWBellSMPotterAMReesRC.Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosom Cancer1997;
19:22–8
4.
OnkenMDWorleyLAPersonECharDHBowcockAMHarbourJW.Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res2007;
13:2923–7
5.
ShieldsCLSayEATHasanreisogluMSaktanasateJLawsonBMLandyJEBadamiAUSivalingamMDHauschildAJHouseRJDaitchZEMashayekhiAShieldsJAGangulyA.Personalized prognosis of uveal melanoma based on cytogenetic profile in 1059 patients over an 8-Year period: the 2017 Harry S. Gradle lecture. Ophthalmology2017;
124:1523–31
6.
DamatoBDopieralaJACouplandSE.Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res2010;
16:6083–92
7.
KujalaEMäkitieTKiveläT.Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci2003;
44:4651–9
8.
FigueiredoCRKaliraiHSaccoJJAzevedoRADuckworthASlupskyJRCoulsonJMCouplandSE.Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. J Pathol2020;
250:420–39
9.
OnkenMDWorleyLAEhlersJPHarbourJW.Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res2004;
64:7205–9
10.
OnkenMDWorleyLACharDHAugsburgerJJCorreaZMNudlemanEAabergTMJrAltaweelMMBardensteinDSFingerPTGallieBLHarocoposGJHovlandPGMcGowanHDMilmanTMruthyunjayaPSimpsonERSmithMEWilsonDJWirostkoWJHarbourJW.Collaborative ocular oncology group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology2012;
119:1596–603
11.
HarbourJW.A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile. Meth Mol Biol (Clifton, NJ)2014;
1102:427–40
12.
FieldMGHarbourJW.Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin Ophthalmol2014;
25:234–9
13.
FieldMGDecaturCLKurtenbachSGezginGvan der VeldenPAJagerMJKozakKNHarbourJW.PRAME as an independent biomarker for metastasis in uveal melanoma. Clin Cancer Res2016;
22:1234–42
14.
RobertsonAGShihJYauCGibbEAObaJMungallKLHessJMUzunangelovVWalterVDanilovaLLichtenbergTMKucherlapatiMKimesPKTangMPensonABaburOAkbaniRBristowCAHoadleyKAIypeLChangMTCherniackADBenzCMillsGBVerhaakRGWGriewankKGFelauIZenklusenJCGershenwaldJESchoenfieldLLazarAJAbdel-RahmanMHRoman-RomanSSternMHCebullaCMWilliamsMDJagerMJCouplandSEEsmaeliBKandothCWoodmanSE.Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell2017;
32:204–20.e15
15.
SouriZWierengaAPAMulderAJochemsenAGJagerMJ.HLA expression in uveal melanoma: an indicator of malignancy and a modifiable immunological target. Cancers2019;
11:1132
16.
BreuerKForoushaniAKLairdMRChenCSribnaiaALoRWinsorGLHancockREBrinkmanFSLynnDJ.InnateDB: systems biology of innate immunity and beyond – recent updates and continuing curation. Nucleic Acids Res2013;
41:D1228–33
17.
WilkersonMDHayesDN.ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics2010;
26:1572–3
18.
CibulskisKLawrenceMSCarterSLSivachenkoAJaffeDSougnezCGabrielSMeyersonMLanderESGetzG.Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol2013;
31:213–9
19.
GeeleherPCoxNHuangRS.pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PloS One2014;
9:e107468
20.
TrapnellCCacchiarelliDGrimsbyJPokharelPLiSMorseMLennonNJLivakKJMikkelsenTSRinnJL.The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol2014;
32:381–6
21.
LangfelderPHorvathS.WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics2008;
9:559
22.
HänzelmannSCasteloRGuinneyJ.GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform2013;
14:1–15
ThorssonVGibbsDLBrownSDWolfDBortoneDSOu YangTHPorta-PardoEGaoGFPlaisierCLEddyJAZivECulhaneACPaullEOSivakumarIKAGentlesAJMalhotraRFarshidfarFColapricoAParkerJSMoseLEVoNSLiuJLiuYRaderJDhankaniVReynoldsSMBowlbyRCalifanoACherniackADAnastassiouDBedognettiDMokrabYNewmanAMRaoAChenKKrasnitzAHuHMaltaTMNoushmehrHPedamalluCSBullmanSOjesinaAILambAZhouWShenHChoueiriTKWeinsteinJNGuinneyJSaltzJHoltRARabkinCSLazarAJSerodyJSDemiccoEGDisisMLVincentBGShmulevichI.The immune landscape of cancer. Immunity2018;
48:812–30.e14
25.
JiaoXShermanBTHuang daWStephensRBaselerMWLaneHCLempickiRA.DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics2012;
28:1805–6
ZhangZ.Variable selection with stepwise and best subset approaches. Ann Transl Med2016;
4:136
29.
GhoshDChinnaiyanAM.Classification and selection of biomarkers in genomic data using LASSO. J Biomed Biotechnol2005;
2005:147–54
30.
ZhengDDingYMaQZhaoLGuoXShenYHeYWeiWLiuF.Identification of serum MicroRNAs as novel biomarkers in esophageal squamous cell carcinoma using feature selection algorithms. Front Oncol2018;
8:674
31.
DanilovaLHoWJZhuQVithayathilTDe Jesus-AcostaAAzadNSLaheruDAFertigEJAndersRJaffeeEMYarchoanM.Programmed cell death ligand-1 (PD-L1) and CD8 expression profiling identify an immunologic subtype of pancreatic ductal adenocarcinomas with favorable survival. Cancer Immunol Res2019;
7:886–95
32.
CharoentongPFinotelloFAngelovaMMayerCEfremovaMRiederDHacklHTrajanoskiZ.Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep2017;
18:248–62
33.
MaoQWangLGoodisonSSunY. Dimensionality reduction via graph structure learning. In: Proceedings of the 21th ACM SIGKDD international conference on knowledge discovery and data mining. Sydney, NSW, Australia: Association for Computing Machinery, 2015, pp.765–774.
34.
NoyRPollardJW.Tumor-associated macrophages: from mechanisms to therapy. Immunity2014;
41:49–61
35.
BronkhorstIHJagerMJ.Inflammation in uveal melanoma. Eye (Lond)2013;
27:217–23
36.
BronkhorstIHLyLVJordanovaESVrolijkJVersluisMLuytenGPJagerMJ.Detection of M2-macrophages in uveal melanoma and relation with survival. Invest Ophthalmol Vis Sci2011;
52:643–50
37.
WangYXuYDaiXLinXShanYYeJ.The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma. Exp Eye Res2020;
196:108069
38.
LiYZHuangYDengXYTuCS.Identification of an immune-related signature for the prognosis of uveal melanoma. Int J Ophthalmol2020;
13:458–65
39.
Marin-AcevedoJADholariaBSoyanoAEKnutsonKLChumsriSLouY.Next generation of immune checkpoint therapy in cancer: new developments and challenges. J Hematol Oncol2018;
11:39
40.
AmaroAGangemiRPiaggioFAngeliniGBarisioneGFerriniSPfefferU.The biology of uveal melanoma. Cancer Metastasis Rev2017;
36:109–40
41.
LeeJKimKECheonSSongJHHouhYKimTSGilMLeeKJKimSKimDHurDYYangYBangSIParkHJChoD.Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin. Oncotarget2016;
7:65825–36
42.
PazHTsoiJKalbasiAGrassoCSMcBrideWHSchaueDButterfieldLHMaurerDMRibasAGraeberTGEconomouJS.Interleukin 32 expression in human melanoma. J Transl Med2019;
17:113
43.
SorrentinoCDi CarloE.Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am J Respir Crit Care Med2009;
180:769–79
44.
IshigamiSArigamiTUchikadoYSetoyamaTKitaYSasakiKOkumuraHKuraharaHKijimaYHaradaAUenoSNatsugoeS.IL-32 expression is an independent prognostic marker for gastric cancer. Med Oncol2013;
30:472
45.
van EssenTHvan PeltSIBronkhorstIHVersluisMNématiFLaurentCLuytenGPvan HallTvan den ElsenPJvan der VeldenPADecaudinDJagerMJ.Upregulation of HLA expression in primary uveal melanoma by infiltrating leukocytes. PloS One2016;
11:e0164292
46.
FanLLiLHuangCHuangSDengJXiongJ.Increased SNX20 and PD-L1 levels can predict the clinical response to PD-1 inhibitors in lung adenocarcinoma. Onco Targets Ther2020;
13:10075–85
47.
FaragoMYarnitzkyTShalomBKatzavS.Vav1 mutations: what makes them oncogenic?Cell Signal2020;
65:109438
48.
RuizSSantosEBusteloXR.The use of knockout mice reveals a synergistic role of the Vav1 and Rasgrf2 gene deficiencies in lymphomagenesis and metastasis. PloS One2009;
4:e8229
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
